Center Hospitalier Universitaire d'Angers
Angers 49933 Cedex 09
0 studies enrolling now · 5 studies all time
What they study most
Acute Myeloid Leukemia, Antimetabolites, Antineoplastic, Carcinoma, Non-Small Cell Lung, Cutaneous Squamous Cell Cancer, Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, Endocrine System Diseases, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Exocrine Pancreatic Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Studies at this site
- A Study of Sigvotatug Vedotin in Advanced Solid Tumors — Recruiting now
- Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) — Completed
- KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment — Status unconfirmed
- KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera — Running, not enrolling
- Vadastuximab Talirine (SGN-CD33A; 33A) Combined With Azacitidine or Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia — Stopped early